Urology Annals
About UA | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionLogin 
Urology Annals
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 368   Home Print this page  Email this page Small font size Default font size Increase font size
This article has been cited by
1COMMD3:BMI1 Fusion and COMMD3 Protein Regulate C-MYC Transcription: Novel Therapeutic Target for Metastatic Prostate Cancer
Syed Umbreen,Mudassir Meraj Banday,Anmbreen Jamroze,Adrian P. Mansini,Arsheed A. Ganaie,Marina G. Ferrari,Raihana Maqbool,Firdous H. Beigh,Paari Murugan,Colm Morrissey,Eva Corey,Badrinath R. Konety,Mohammad Saleem
Molecular Cancer Therapeutics.2019;18(11)2111
[DOI]
2Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA
Ce Wang,Naseruddin Höti,Tung-Shing Mamie Lih,Lori J. Sokoll,Rui Zhang,Zhen Zhang,Hui Zhang,Daniel W. Chan
Clinical Proteomics.2019;16(1)2111
[DOI]
3Prostate cancer aggressive prediction: preponderant diagnostic performances of intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) beyond ADC at 3.0 T scanner with gleason score at final pathology
Yingchan Shan,Xiaoshan Chen,Kai Liu,Mengsu Zeng,Jianjun Zhou
Abdominal Radiology.2019;44(10)3441
[DOI]
  Feedback 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal